Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Blood Specimen Collection 19 Surveys and Questionnaires 18 Specimen Handling 16 Radiotherapy 7 Magnetic Resonance Spectroscopy 7 Surgical Procedures, Operative 6 trastuzumab deruxtecan 5 Observation 5 Data Collection 5 darolutamide 4 Patient Reported Outcome Measures 4 Magnetic Resonance Imaging 4 Cryosurgery 4 Breath Tests 4 Biopsy 4 ribociclib 3 atezolizumab 3 Watchful Waiting 3 Ultrasonography 3 Tomography, X-Ray Computed 3 Standard of Care 3 Radiation 3 Mental Status and Dementia Tests 3 Letrozole 3 Interviews as Topic 3 Immune Checkpoint Inhibitors 3 Hepatectomy 3 Bevacizumab 3 palbociclib 2 lorlatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × ravulizumab × 30 days × Clear all

NCT06909253 2026-05-15

MG-ARCADIA

AstraZeneca

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡